Clinical Trial

An Acupuncture Study for People At High Risk for Sepsis

Study acronym: ACTIONS
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Researchers think acupuncture may improve outcomes for participants with sepsis, based on laboratory studies and previous studies in people with sepsis. The purpose of this study to see whether real acupuncture can improve outcomes for participants with sepsis when compared to sham acupuncture. Sham acupuncture is performed the same way as real acupuncture but will use different needles and target different sites or places on the body than real acupuncture.
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-07-22
notable Sponsor changed: Memorial Sloan Kettering Cancer Center -> University of California, Irvine 2026-07-22
Trial Details
NCT Number NCT06344819
Lead Sponsor University of California, Irvine
Collaborators: National Cancer Institute (NCI)
Conditions Sepsis
Enrollment 78 participants
Start Date 2024-03-20
Primary Completion 2028-03-20 (estimated)
Study Completion 2028-03-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-21